SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-23-001354
Filing Date
2023-10-04
Accepted
2023-10-03 21:31:25
Documents
17
Period of Report
2023-10-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea186294-6k_immuron.htm 6-K 14052
2 IMMURON CEO, STEVEN LYDEAMORE TO PRESENT AT LD MICRO ea186294ex99-1_immuron.htm EX-99.1 31363
3 GRAPHIC image_001.jpg GRAPHIC 1254
4 GRAPHIC ex99-1_001.jpg GRAPHIC 679631
5 GRAPHIC ex99-1_002.jpg GRAPHIC 429202
6 GRAPHIC ex99-1_003.jpg GRAPHIC 555053
7 GRAPHIC ex99-1_004.jpg GRAPHIC 832151
8 GRAPHIC ex99-1_005.jpg GRAPHIC 857068
9 GRAPHIC ex99-1_006.jpg GRAPHIC 938267
10 GRAPHIC ex99-1_007.jpg GRAPHIC 892401
11 GRAPHIC ex99-1_008.jpg GRAPHIC 886886
12 GRAPHIC ex99-1_009.jpg GRAPHIC 740507
13 GRAPHIC ex99-1_010.jpg GRAPHIC 919511
14 GRAPHIC ex99-1_011.jpg GRAPHIC 723076
15 GRAPHIC ex99-1_012.jpg GRAPHIC 778148
16 GRAPHIC ex99-1_013.jpg GRAPHIC 351218
17 GRAPHIC ex99-1_014.jpg GRAPHIC 1249252
  Complete submission text file 0001013762-23-001354.txt   14967830
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 231306454
SIC: 2834 Pharmaceutical Preparations